arrow_back Trending Legislation
Share share

Medicare: Testing Coverage for Low Vision Devices

This act establishes a five-year Medicare pilot program to evaluate the financial impact of covering specialized low vision devices. The goal is to determine if these devices should be permanently covered, potentially improving access to essential visual aids for many citizens.
Key points
Medicare will begin testing coverage for low vision devices, such as magnifiers or image enhancers, which are not ordinary eyeglasses.
The program will run for 5 years nationwide, aiming to assess the financial impact on the insurance system.
Participants must have a prescription from an ophthalmologist or optometrist certifying medical necessity for the device.
Results will help decide if these devices become permanent Medicare benefits, potentially improving the quality of life for individuals with severe vision impairment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Medicare Demonstration of Coverage for Low Vision Devices Act of 2022
Print number: HR 6848
Sponsor: Rep. Maloney, Carolyn B. [D-NY-12]
Process start date: 2022-02-25